RxDoctor Payments Data

Leona Holmberg

Hematology & Oncology · Seattle, WANPI 1720163538

Payments from drug & device makers

$186,386in general payments, 2019–2025

Across 10 payments — averaging $18,639 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$180K
  • Seagen Inc.$6K
  • National Marrow Donor Program$215
  • E.r. Squibb & Sons, L.L.C.$24

What the payments were for

  • Travel & lodging$2410%
  • Food & beverage$21590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$186,386 in reported general payments places this provider in the 70th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Medicare billing

Part B allowed, 2024
$8,147
Medicare patients
22
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →